The most frequently mutated genes after TP53 were DNMT3A (31/324, 10%), ASXL1 (29/319, 9%), and TET2 (27/318, 8%), all at rates lower than observed in MDS cohorts unselected by karyotype. The gene discussed is TP53; the disease is myelodysplastic syndrome.